News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Interleukin Genetics Inc. (ILGN) Enters Into New Agreements And Amends Agreements With Alticor, Inc.


2/28/2006 12:38:44 PM

WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 28, 2006--Interleukin Genetics, Inc. (AMEX:ILI) reported today that it has signed two new Purchase Agreements for genetic tests with Access Business Group International LLC, a subsidiary of Alticor Inc. Interleukin also reported that it has amended its Note Purchase and Stock Purchase Agreements with Pyxis Innovations, Inc., another affiliate of Alticor, to provide Interleukin with access to up to an additional $3.5 million of borrowing for general working capital purposes.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES